Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature

Clin Genitourin Cancer. 2020 Aug;18(4):e473-e477. doi: 10.1016/j.clgc.2019.12.016. Epub 2020 Jan 7.

Authors

Leslie Ballas¹, Oren Wei², Siamak Daneshmand³, Anne Schuckman³, Hooman Djaladat³, Monish Aron³, Anishka D'Souza⁴, David Quinn⁴, Tanya B Dorff²

Affiliations

¹ Department of Radiation Oncology, University of Southern California Keck School of Medicine, Los Angeles, CA. Electronic address: lballas@med.usc.edu.
² Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA.
³ Institute of Urology, University of Southern California Keck School of Medicine, Los Angeles, CA.
⁴ Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA.

PMID: 32044240
DOI: 10.1016/j.clgc.2019.12.016

No abstract available

Keywords: Combined modality therapy; Local control; Radiotherapy; Recurrent bladder cancer; Urothelial carcinoma.

Publication types

Case Reports
Research Support, N.I.H., Extramural
Review

MeSH terms

Aged
Aged, 80 and over
Chemoradiotherapy / methods*
Disease Management
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / therapy*
Neoplasm, Residual / pathology
Neoplasm, Residual / therapy*
Prognosis
Urinary Bladder Neoplasms / pathology
Urinary Bladder Neoplasms / therapy*

Grants and funding

P30 CA014089/CA/NCI NIH HHS/United States